Search Tag: ECMO
2026 14 May
The ELMOH (ExtracorporeaL life support and Modification Of Hemostasis) trial investigated how coagulation changes during the first 48 hours of extracorporeal membrane oxygenation (ECMO) and whether these changes differ between venovenous (VV) and venoarterial (VA) ECMO. ECMO is increasingly used in critically ill patients with severe respiratory o1Read more
2026 04 Mar
A recent study investigated the prevalence, determinants, and prognostic implications of pulmonary hypertension (PH) in patients with acute respiratory distress syndrome (ARDS) supported with veno-venous extracorporeal membrane oxygenation (V-V ECMO). PH, defined as a mean pulmonary artery pressure (mPAP) greater than 20 mmHg, is a recognised comp1Read more
2025 28 Jul
Prognostic models in intensive care units (ICUs) have been developed to inform clinical decision making by predicting critical outcomes such as septic shock, kidney injury or mortality. Despite promising accuracy in research settings, the practical application of these models often falls short in improving patient-centred outcomes. One key re1Read more
2025 28 Jul
Prognostic models in intensive care units (ICUs) have been developed to inform clinical decision making by predicting critical outcomes such as septic shock, kidney injury or mortality. Despite promising accuracy in research settings, the practical application of these models often falls short in improving patient-centred outcomes. One key re1Read more
2025 03 Jul
Most critical care trials studying mortality have inconclusive results due to factors like ineffective interventions, small sample sizes, treatment heterogeneity, and unrealistic assumptions about effect sizes in power calculations. Determining sample size requires balancing statistical power with feasibility. Many ICU trials are underpowered, usi1Read more
2025 27 May
Rapid technological advancements and evolving clinical roles are transforming the landscape of cardiac anaesthesia, reshaping how clinicians care for the most vulnerable patients. From navigating the technical challenges of the catheterisation laboratory to mastering the intricacies of extracorporeal membrane oxygenation (ECMO), today’s cardiac an1Read more
2024 14 Oct
Extracorporeal membrane oxygenation (ECMO) is used to support critically ill patients, but its impact on antimicrobial pharmacokinetics (PK) and pharmacodynamics (PD) presents significant challenges. ECMO circuits can affect drug delivery, leading to the sequestration of drugs, changes in the volume of distribution (Vd), decreased clearance, and l1Read more
2024 09 Sep
In patients with severe acute respiratory distress syndrome (ARDS), managing gas exchange and avoiding ventilation-induced lung injury (VILI) are key challenges. Venovenous extracorporeal membrane oxygenation (ECMO) is used for severe ARDS with persistent hypoxaemia, effectively improving gas exchange and reducing ventilation pressures, though1Read more
2024 09 Sep
Extracorporeal membrane oxygenation (ECMO) use is on the rise, but patients on ECMO often experience major complications, such as acute brain injury (ABI), which doubles or triples in-hospital mortality rates. ABI is more prevalent in venoarterial (VA) ECMO compared to venovenous (VV) ECMO, especially in cases involving extracorporeal cardiopulmon1Read more
2024 22 Jun
With the global demand for organ transplants on the rise, the shortage of available organs has worsened, leaving the supply insufficient to meet the growing need. One way to address this crisis is to identify potential organ donors, particularly by screening for brain death in ICUs, especially after cardiac arrest. Extracorporeal cardiop1Read more
2023 06 Dec
The effectiveness of prone positioning to improve outcomes in patients with severe acute respiratory distress syndrome (ARDS) undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO) compared to supine positioning is unknown. The PRONECMO multicenter randomised clinical trial aimed to address the lack of robust evidence regarding p1Read more
2023 08 Nov
The use of extracorporeal membrane oxygenation (ECMO) has risen significantly as a rescue therapy for respiratory issues, including those caused by viral infections. Patients on ECMO frequently experience complications like thrombotic events and major bleeding, which are considered ECMO-related issues. However, infections are typically attributed 1Read more
2023 13 Oct
Xenios sponsored a lunch symposium at the 16th European Conference on Paediatric and Neonatal Ventilation (EPNV) in Montreux (CH) in May 2023. Matteo Di Nardo (Italy) introduced the audience to extracorporeal membrane oxygenation (ECMO) in neonates. Florian Kipfmüller (Germany) presented current knowledge and his experience with ECMO in neonates1Read more
2023 28 Jun
A recent review explored the extent and quality of literature investigating the influence of social determinants of health (SDoH) on extracorporeal membrane oxygenation (ECMO) utilisation and outcomes among children and adults. The researchers examined the relationship between factors like socioeconomic status, education, and access to healthcare 1Read more
2023 20 Apr
When patients are critically ill, one or more organs may not function optimally or even fail, so organ support is an important component of ICU management. However, organ support can be associated with complications such as infections, bleeding, and damage to surrounding tissue or organs. These complications can alter the patient's conditi1Read more
2023 20 Apr
During artificial organ support, kidney injury is multifactorial and related to the high severity of patients treated with extracorporeal membrane oxygenation (ECMO). The successful delivery of continuous renal replacement therapy (CRRT) during ECMO requires a clear prescription of the target solute clearance and fluid removal rate based on the 1Read more
2023 20 Apr
Extracorporeal membrane oxygenation is a resource that is accessible in hospitals and intensive care units all over the world. In serious situations, ECMO therapy is intended to provide haemodynamic and/or ventilatory support. Because of this, many people refer to the ECMO patient as "the most critical patient." As a result, there is a very high1Read more
2023 15 Feb
There is increasing evidence supporting the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in patients that do not respond to maximal medical therapy. ARDS can occur in some COVID-19 patients who are hospitalised, and ECMO can be utilised as a treatment option in some cases. Using ECMO can h1Read more
2022 23 Nov
Extracorporeal membrane oxygenation (ECMO) refers to mechanical support in patients for heart or lung function during cardiopulmonary failure. ECMO is used when conventional treatments have failed. As per the international guideline of the Extracorporeal Life Support Organization (ELSO), ECMO should be considered when the estimated mortality risk 1Read more
2022 05 Jul
There have been conflicting results concerning lung recruitability of COVID-19 acute respiratory distress syndrome (ARDS) and the use of techniques derived from changes in respiratory mechanics and/or gas exchange in response to positive end-expiratory pressure (PEEP) increase. Various factors may explain the heterogeneity of reports regarding rec1Read more
2021 01 Sep
At the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine this week, Professor Alain Combes of Sorbonne University, Paris, talked about treating COVID-19 patients with the most severe forms of cardiac and respiratory failure. Prof Combes talked about his experience during the pandemic and presented his research that com1Read more
2021 17 Aug
There is sufficient evidence to show that prone positioning improves oxygenation and respiratory mechanics and is also associated with lower mortality in patients with moderate to severe ARDS. However, some patients can develop refractory hypoxaemia and hypercapnia that could require the use of venovenous extracorporeal membrane oxygenation (VV-EC1Read more
2021 02 Jul
As a cardiac surgeon with extensive experience of lung transplantations, Dr. Wojciech Karolak is used to performing complicated procedures. However, a recent case involving a critically ill female COVID-19 patient on Extracorporeal Membrane Oxygenation (ECMO) became an extraordinary lifesaving experience. “The lung transplant cured the patien1Read more
2021 22 Jun
Extracorporeal membrane oxygenation (ECMO) has been used in patients with COVID-19 who develop severe acute respiratory distress syndrome (ARDS). ECMO has previously been used in other infectious outbreaks, including the 2009 influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) outbreak. The Extracorporeal Life Su1Read more
2021 01 Feb
An in-depth analysis was conducted in Germany to evaluate whether mortailty in Germany in Extracorporeal life support (ECLS) therapy differed from previously reported literature. Extracorporeal life support (ECLS) is a critical component of intensive care therapy. There are various conditions that require the use of ECLS. The term ECLS encom1Read more
2020 30 Apr
As the coronavirus spreads and infections with COVID-19 further increase throughout Europe, ECMO therapy turns out to be a necessary option for patients with severe courses. Xenios AG , a subsidiary of Fresenius Medical Care, provides ECMO consoles that can be used for the treatment of patients who develop severe pneumonia and ARDS with lu1Read more
2020 16 Mar
COVID-19 is associated with severe disease requiring intensive care in approximately 5% of proven infections. As with similar outbreaks in the past, including SARS, MERS, A(H7N9), and H1N1, critical care continues to be an integral component of the global response to Coronavirus. You might also like : Coronavirus and the Potential Role of 1Read more